Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1608 of 6351
-
AI takes on diabetes: could a smartphone app beat standard care?
Disease control Recruiting nowPurpose: To evaluate the efficacy of artificial intelligence (AI)-based decision-making technology in managing glycated hemoglobin (HbA1c) and blood glucose levels compared to the control group. Methods: For the AI Intervention group, the patients will be trained to independentl…
Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to stall lung cancer progression
Disease control Recruiting nowThe goal of this clinical trial is to learn if spatially fractionated radiotherapy (SFRT) combined with standard systemic therapy can treat oligoprogressive non-small cell lung cancer (NSCLC) in patients who have progressed after at least one line of systemic therapy. The main qu…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New 20-Strain pneumonia vaccine trial launches in china
Vaccine OngoingThe purpose of this study is to learn about the safety of the 20-valent pneumococcal conjugate vaccine (20vPnC) among adults, children, and infants, as well as the immunogenicity of 20vPnC among infants and children under 2 years of age in China. This vaccine will be given as per…
Phase 1 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
Hope for takayasu patients: study tests stopping biologic drugs after years of remission
Disease control Recruiting nowTakayasu arteritis is a chronic large-vessel vasculitis affecting the aorta and its major branches. Biologic therapies such as tumor necrosis factor inhibitors and tocilizumab are commonly used in patients with refractory or relapsing disease. However, there is limited evidence r…
Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can VR help kids with autism learn social cues?
Symptom relief By invitation onlyAutism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impairments in social communication and interaction, as well as restricted and repetitive behaviors. Behavioral and educational interventions are considered the most effective approaches to improve …
Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New cocktail of drugs aims to boost stomach cancer treatment
Disease control Recruiting nowImmunotherapy combined with chemotherapy has become the standard first-line treatment regimen for gastric cancer. However, a subset of patients still fail to benefit or derive only limited benefit from this approach. This study aims to evaluate the addition of immunomodulatory EZ…
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New antibiotic beads aim to heal bone infections in bedsores
Disease control Recruiting nowThe purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage…
Phase 2 • Sponsor: Biocomposites Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Laser etching could give dental implants a stronger gum seal
Disease control CompletedIntroduction: Tight soft tissue integration to the dental implants is essential to achieve a successful outcome of dental implants. Contamination by oral bacteria of the implant-mucosa interface can result in gingival recession, pocket formation, and bone resorption. There are ma…
Sponsor: Alexandria University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for kids with kidney disease: drug trial targets protein leak
Disease control Recruiting nowThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy following ravulizumab IV dosing in pediatric participants with IgAN or IgAVN.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a special catheter coating stop infections before they start?
Disease control CompletedThis single-centre randomised pilot and feasibility study assessed whether an anti-fouling zwitterionic silicone urinary catheter can be deployed and evaluated in frail, elderly adults who require long-term indwelling catheterisation. In the experimental catheter, a zwitterionic …
Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could older kidney patients take fewer drugs? new trial aims to find out
Disease control Recruiting nowThe purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of ca…
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
A 4-Pronged therapy tackles fibromyalgia from all angles
Symptom relief CompletedStudy Objective The project aims to implement an interdisciplinary therapeutic program for people suffering from persistent pain (specifically fibromyalgia) to optimize their quality of life through a comprehensive approach that addresses physical, psychological, social, and nutr…
Sponsor: Playa Ancha University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Could less be more? new trial aims to protect preemie brains from bleeding
Disease control Recruiting nowThe objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postme…
Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for advanced cancer? ZG005 drug trial begins
Disease control OngoingThis is an open-label, multicenter, Phase II clinical trial, designed to evaluate the efficacy and safety of ZG005 in patients with advanced solid tumors who have previously failed or are intolerant to standard treatment.
Phase 2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Long-COVID mystery: new study aims to decode patient subtypes
Knowledge-focused Recruiting nowThe study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Light therapy may ease chemo brain fog in breast cancer survivors
Symptom relief Recruiting nowBreast cancer is one of the most common cancers in metropolitan France, with over 60,000 new cases in 2023. Mostly a female cancer, it can affect a young population, with around 20% of breast cancers occurring in women under 50. Treatment is mainly based on surgery, chemotherapy,…
Sponsor: Centre Hospitalier de Valenciennes • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Spinal zaps may help kids with paralysis grip again
Disease control By invitation onlyThe main goal of this pilot study is to find the best ways to use transcutaneous spinal cord stimulation (scTS) to improve hand function in children with spinal cord injuries (SCI). The investigators will start by exploring the best places and strengths for applying scTS on the n…
Sponsor: University of Louisville • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart valve repair patients: which blood thinner is safest?
Disease control Recruiting nowMitral regurgitation (MR) is the most common valvular heart disease, affecting approximately 24.2 million people worldwide (with a higher prevalence in older age groups). Transcatheter edge-to-edge repair (TEER) is now a well-established strategy in high-risk patients with MR. Gl…
Phase 4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to lift depression in breast cancer survivors with tailored support
Symptom relief Recruiting nowBreast cancer is the most common cancer among women worldwide, and many survivors experience comorbid mental health conditions such as depression and anxiety, which can significantly worsen health outcomes and increase mortality. This large-scale trial in Pakistan aims to evaluat…
Sponsor: Pakistan Institute of Living and Learning • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Could a daily electrolyte drink sharpen your mind?
Symptom relief CompletedThis study evaluates the effects of Artah's Cellular Hydration electrolyte supplement on cognitive function and energy levels in healthy adults aged 25-60 who experience mild to moderate fatigue, brain fog, or related symptoms. The trial is a single-arm, unblinded, virtual study …
Sponsor: Artah Nutrition Limited • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC